A
13.08
0.07 (0.54%)
| Previous Close | 13.01 |
| Open | 13.04 |
| Volume | 341,075 |
| Avg. Volume (3M) | 387,532 |
| Market Cap | 540,451,392 |
| Price / Earnings (Forward) | 96.15 |
| Price / Sales | 1.71 |
| Price / Book | 3.10 |
| 52 Weeks Range | |
| Earnings Date | 14 Jul 2026 |
| Profit Margin | -11.62% |
| Operating Margin (TTM) | -4.53% |
| Diluted EPS (TTM) | -0.830 |
| Quarterly Revenue Growth (YOY) | 12.90% |
| Total Debt/Equity (MRQ) | 5.54% |
| Current Ratio (MRQ) | 2.21 |
| Operating Cash Flow (TTM) | -10.13 M |
| Levered Free Cash Flow (TTM) | 2.21 M |
| Return on Assets (TTM) | -5.03% |
| Return on Equity (TTM) | -17.50% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | AngioDynamics, Inc. | Mixed | Bullish |
AIStockmoo Score
0.7
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.67 |
|
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 6.84% |
| % Held by Institutions | 92.87% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Systematic Financial Management Lp | 31 Mar 2026 | 2,453,701 |
| Broadfin Holdings Llc | 31 Mar 2026 | 2,069,333 |
| Kotler Kevin | 31 Dec 2025 | 1,713,789 |
| Bastion Asset Management Inc. | 31 Mar 2026 | 1,313,002 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |